The impact of remdesivir on SARS-CoV-2 evolution in vivo
Ted Ling-Hu(Northwestern University), Judd F. Hultquist(Northwestern University), Arghavan Alisoltani(Northwestern University), Alexandre Machado de Sant’Anna Carvalho(Northwestern University), Ramón Lorenzo-Redondo, Estefany Rios-Guzman(Johns Hopkins University), Lacy M. Simons(Northwestern University), Maria Francesca Reyes Agnes(Northwestern University), Egon A. Ozer(Northwestern University)
Cited by 6
Related Papers
Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic
|Nature Communications|2024|83
Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era
|Viruses|2022|50
Antibody escape and global spread of SARS-CoV-2 lineage A.27
|Nature Communications|2022|34
Clinical and biological consequences of respiratory syncytial virus genetic diversity
|Therapeutic Advances in Infectious Disease|2022|32